Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Journal of Neurology|February 4, 2026
Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab-A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS)Daniel Engels, Mariella Herfurth, Joachim Havla, et al.BMJ Neurology Open|October 24, 2025
Dyadic Coping of NMOSD and MOGAD patients and their partners: a sociological and psychological examination of strategies (CoMMOnsense-Study)Anna Walz, Daria Tkachenko, Martin W Hümmert, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 31, 2024
Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study)Sarah Passoke, Carlotta Stern, Vivien Häußler, et al.Neurology|July 2, 2026
Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort StudyDaniel Engels, Patrick Schindler, Joachim Havla, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 4, 2024
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacksCarolin Schwake, Theodoros Ladopoulos, Vivien Häußler, et al.Journal of Neurology|December 21, 2024
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and visionMihaela Nicolescu, Vivien Häußler, Friedemann Paul, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 27, 2024
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGADVivien Häußler, Corinna Trebst, Daniel Engels, et al.Annals of Neurology|December 12, 2023
Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGADAnkelien Duchow, Judith Bellmann-Strobl, Tim Friede, et al.Frontiers in Immunology|April 28, 2025
Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study)Julian Reza Kretschmer, Daria Tkachenko, Tania Kümpfel, et al.Pageof 2